Trending...
- National Minority Health Association Launches "Equity for All."
- Green Office Partner Launches Managed Print Services Program in Canada
- "Street Fighter™ 6" Panel Announced for December 2nd at Los Angeles Comic Con; The Music of Street Fighter 6: A Special Look at the Video Game
Cardiovascular Imaging Expert to Lead Core Lab Services in Support of Clinical Trials
BOSTON - PRDelivery -- As cardiac imaging becomes more integrated in both clinical practice and research, Cardiovascular Clinical Sciences (CCS) announced today the appointment of Dr. Jing Dai as the new Director of Core Lab Operations.
Dr. Dai is a highly accomplished medical professional with an impressive academic background, having earned both an M.D. and Ph.D. from Peking University Health Science Center. With expertise in angiographic and CT imaging, she has played a vital role in numerous clinical studies at Beth Israel Deaconess Medical Center, evaluating a wide range of cardiovascular devices and technologies, including bare metal stents, drug-eluting stents, bioabsorbable scaffolds, drug-coated balloons, TAVR, and TMVR devices.
In addition to her clinical research experience, Dr. Dai has more than ten years of experience in the basic cardiovascular research field. Her research has made significant contributions to the understanding of the molecular mechanisms underlying atherosclerosis and dilated cardiomyopathy. Her dedication to advancing the field of cardiovascular research is reflected in her publications and her role as a reviewer for more than 20 prestigious journals.
More on PR Delivery
"As the new Director of Core Lab Operations, Dr. Dai brings her wealth of knowledge and expertise to lead the lab's efforts to advance the understanding of cardiovascular disease and improve patient outcomes," says Dr. Lorraine Rusch, CEO of CCS. "We are confident in her leadership, and that her dedication and extensive experience will prove invaluable to the continued success of the lab."
CCS was founded in 1997 as a cardiovascular specific Contract Research Organization (CRO) by Dr. Marvin Konstam and Dr. James Udelson of Tufts Medical Center. It has established itself as the CRO of choice for pharmaceutical, biotechnology and medical device companies looking to conduct research to manage and treat cardiovascular diseases.
To learn more about CCS and services it provides the life sciences industry, please visit www.ccstrials.com
Dr. Dai is a highly accomplished medical professional with an impressive academic background, having earned both an M.D. and Ph.D. from Peking University Health Science Center. With expertise in angiographic and CT imaging, she has played a vital role in numerous clinical studies at Beth Israel Deaconess Medical Center, evaluating a wide range of cardiovascular devices and technologies, including bare metal stents, drug-eluting stents, bioabsorbable scaffolds, drug-coated balloons, TAVR, and TMVR devices.
In addition to her clinical research experience, Dr. Dai has more than ten years of experience in the basic cardiovascular research field. Her research has made significant contributions to the understanding of the molecular mechanisms underlying atherosclerosis and dilated cardiomyopathy. Her dedication to advancing the field of cardiovascular research is reflected in her publications and her role as a reviewer for more than 20 prestigious journals.
More on PR Delivery
- Unlocking the Magic of Miami Beach
- Introducing Scuba Diving Industry Magazine
- The Five Pillars of Success Pillar One Strengths Outlined by Rosann Santos CPC
- Pitch Black Appoints New Chief People Officer
- Emmy Award Winning Journalist Joins Prominent Haddonfield Real Estate Agency
"As the new Director of Core Lab Operations, Dr. Dai brings her wealth of knowledge and expertise to lead the lab's efforts to advance the understanding of cardiovascular disease and improve patient outcomes," says Dr. Lorraine Rusch, CEO of CCS. "We are confident in her leadership, and that her dedication and extensive experience will prove invaluable to the continued success of the lab."
CCS was founded in 1997 as a cardiovascular specific Contract Research Organization (CRO) by Dr. Marvin Konstam and Dr. James Udelson of Tufts Medical Center. It has established itself as the CRO of choice for pharmaceutical, biotechnology and medical device companies looking to conduct research to manage and treat cardiovascular diseases.
To learn more about CCS and services it provides the life sciences industry, please visit www.ccstrials.com
Contact
Dr. Lorraine Rusch, President & CEO
Cardiovascular Clinical Sciences
lrusch@ccstrials.com
914-548-1690
Dr. Lorraine Rusch, President & CEO
Cardiovascular Clinical Sciences
lrusch@ccstrials.com
914-548-1690
Source: Cardiovascular Clinical Sciences
0 Comments
Latest on PR Delivery
- REA 'Peace of Mind on the Move' Study achieves Highly Commended recognition in the category Excellence in Coaching by ABP November 2023
- Revolutionizing FEC Chain Stores with Our Cutting-Edge Ordering& Warehousing System
- Media Personality Cyrus Webb celebrates 20 years and over 12,000 guests on Conversations LIVE radio show
- Panovolo for macOS is now available
- Lumena, A New Luxury Oceanfront Condominium Takes Flight on Florida's Space Coast
- Dogs at the Dentist: How an unlikely partnership is helping treat dental anxiety
- SSV Network selects Randamu for Distributed Key Generation (DKG) Grant Award
- Lawmato relaunches its virtual consultation app with enhanced features
- MiBOXER Is Exhibiting At Hong Kong International Autumn Lighting Fair
- Beck Properties Group, eXp Realty Expands Service in Southeast Indiana
- Stonely Unleashes Innovative Platform for Homeowners: Design and Order Kitchen Countertops Online with Ease!
- One Million Pages Read in the First Year !!
- Kingston NY-Based Ryan & Ryan Kicks Off its 65th Anniversary Dec. 6 by Underwriting a Chamber of Commerce Mixer Saluting RUPCO
- Tobu Railway's Hosts "Tokyo Downtown Tour: Bamboo Lighting."
- "Street Fighter™ 6" Panel Announced for December 2nd at Los Angeles Comic Con; The Music of Street Fighter 6: A Special Look at the Video Game
- National Minority Health Association Launches "Equity for All."
- Green Office Partner Launches Managed Print Services Program in Canada
- Vantiva Confirms its Strong Commitment to Diversity, Equity and Inclusion
- The World's No.1 Superstar Rings in 48th Birthday and 25 Years as an Entertainer
- Devart Is the Winner of 2023 New World Report Software and Technology Award